The human renin infused rat: use as an in vivo model for the biological evaluation of human renin inhibitors.
暂无分享,去创建一个
D. Lamarre | P. Anderson | L. Pilote | B. Simoneau | G. Bolger | D. Thibeault | G. Jung | F. Liard | J. Vigeant | J. Jaramillo
[1] J. Deinum,et al. Synthesis and biological activity of potent, low molecular weight renin inhibitors. , 2009, The journal of peptide research : official journal of the American Peptide Society.
[2] S. Neidle,et al. New renin inhibitors containing novel analogues of statine. , 2009, The journal of peptide research : official journal of the American Peptide Society.
[3] P. Anderson,et al. Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy. , 1999, Bioorganic & medicinal chemistry.
[4] R. McKelvie,et al. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. , 1997, Journal of the American College of Cardiology.
[5] Bertram Pitt,et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.
[6] W. Meister,et al. Excretion and metabolism of remikiren, a potent orally active inhibitor of primate renin. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.
[7] L. Tong,et al. Crystallographic Studies on the Binding Modes of P2-P3 Butanediamide Renin Inhibitors (*) , 1995, The Journal of Biological Chemistry.
[8] A. L. McLeod,et al. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig. , 1995, Canadian journal of physiology and pharmacology.
[9] D. Lamarre,et al. Time-resolved ligand exchange reactions: kinetic models for competitive inhibitors with recombinant human renin. , 1995, Journal of medicinal chemistry.
[10] D. Lamarre,et al. Enzymatic characterization of purified recombinant human renin. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[11] W. Frishman,et al. Renin Inhibition: A New Approach to Cardiovascular Therapy , 1994, Journal of clinical pharmacology.
[12] F. Fouad-Tarazi. Hemodynamic effects of inhibitors of the renin-angiotensin system. , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[13] J. Ménard,et al. Effects of Blocking the Angiotensin II Receptor, Converting Enzyme, and Renin Activity on the Renal Hemodynamics of Normotensive Guinea Pigs , 1993, Journal of cardiovascular pharmacology.
[14] A. Fukamizu,et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. , 1993, The Journal of biological chemistry.
[15] P. Kovar,et al. Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. , 1992, Science.
[16] A. Fossa,et al. Synergistic Effect on Reduction in Blood Pressure with Coadministration of the Renin Inhibitor, CP‐80,794, and the Angiotensin Converting Enzyme Inhibitor, Captopril , 1992, Journal of cardiovascular pharmacology.
[17] P. Manunta,et al. Prorenin is present in human red blood cells. , 1991, Canadian journal of physiology and pharmacology.
[18] N. Samani,et al. Vascular renin and hypertension. Uptake versus synthesis. , 1990, American journal of hypertension.
[19] J. A. Lawson,et al. Rat model for evaluating inhibitors of human renin. , 1990, Journal of pharmacological methods.
[20] S. Vatner,et al. Effects of Renin Inhibition in the Conscious Primate Macaca fascicularis , 1989, Hypertension.
[21] J. Wood,et al. CGP 38 560: Orally Active, Low‐Molecular‐Weight Renin Inhibitor with High Potency and Specificity , 1989, Journal of cardiovascular pharmacology.
[22] H. Urata,et al. Evidence for extracellular, but not intracellular, generation of angiotensin II in the rat adrenal zona glomerulosa. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Ménard,et al. Comparative enzymatic studies of human renin acting on pure natural or synthetic substrates. , 1987, Biochimica et biophysica acta.
[24] J. Boger,et al. Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs. , 1984, Hypertension.
[25] J. Sullivan,et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide , 1997, European Journal of Clinical Pharmacology.
[26] R. Panek,et al. Development of a high renin model of hypertension in the cynomolgus monkey. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.
[27] W. Holt,et al. Hemodynamic effects of the renin inhibitor CP-80,794 in several species , 1990 .